Latest News & Updates

Breaking News

  • 22 hours ago

  • Vaibhavi M.

Moleculin Releases Preliminary MIRACLE Trial Data for Annamycin in Relapsed or Refractory AML
Breaking News
Cipla Appoints Sushrut Kulkarni as Global Chief of Integrated Product Development

Vaibhavi M.

Other trending news you may like to read

Moleculin Releases Preliminary MIRACLE Trial Data for Annamycin in Relapsed or Refractory AML

Moleculin releases preliminary Phase 2/3 MIRACLE trial data for Annamycin in R/R AML; n=45 cohort has not yet achieved statistical significance.

Vaibhavi M.

Pharma Now

Cipla Appoints Sushrut Kulkarni as Global Chief of Integrated Product Development

Cipla names Sushrut Kulkarni Global Chief of Integrated Product Development, consolidating R&D and manufacturing pipeline leadership under one role.

Vaibhavi M.

Pharma Now

Glenmark Launches Generic Olanzapine Injection in US After ANDA Approval for $25.4M Market

Glenmark launches FDA-approved generic Olanzapine for Injection in the US, entering a $25.4M market as a therapeutic equivalent to Zyprexa IM.

Vaibhavi M.

Pharma Now

Novartis Acquires Myricx Bio in $1.5bn Deal to Add NMTi ADC Payload Platform

Novartis acquires Myricx Bio for up to $1.5bn, adding an NMTi ADC payload platform targeting resistance to current conjugate classes.

Pharma Now Editorial Team

Pharma Now